APOLLO THERAPEUTICS
Apollo Therapeutics is a collaborative venture between three world-leading UK universities (Imperial College London, University College London and the University of Cambridge) and three global pharmaceutical companies (AstraZeneca, GlaxoSmithKline, Johnson & Johnson Innovation). It provides committed translational funding and drug discovery expertise for novel therapeutics, sourced from the best of British academic research, accelerating them towards the clinic. Apollo’s unique model provides... quick, independent access to the resources to grow innovations and to champion the best of British academic research to industry. Apollo’s experienced team of industry scientists have a proven track record of therapeutic delivery and work in partnership with academics and industry partners, crafting each bespoke project to optimise the chances of long-term success. Apollo Therapeutics aims to create the therapies of the future by partnering with the UK’s globally leading academic science base and UK based Pharma industry to have a real impact on patient treatments and outcomes.
APOLLO THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2016-01-01
Address:
Stevenage, Herefordshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.apollotherapeutics.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
139.38 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Interline Therapeutics
Interline Therapeutics is a drug discovery platform that enables the company to map and correct dysfunctional protein communities.
Current Advisors List
Current Employees Featured
Founder
Investors List
UCL Technology Fund
UCL Technology Fund investment in Venture Round - Apollo Therapeutics
Rock Springs Capital
Rock Springs Capital investment in Venture Round - Apollo Therapeutics
Reimagined Ventures
Reimagined Ventures investment in Venture Round - Apollo Therapeutics
Patient Square Capital
Patient Square Capital investment in Venture Round - Apollo Therapeutics
UCLB
UCLB investment in Seed Round - Apollo Therapeutics
Key Employee Changes
Date | New article |
---|---|
2021-11-18 | Apollo Therapeutics Appoints Dr. Sanjay Aggarwal as Chief Medical Officer, Opens U.S. Facility |
Official Site Inspections
http://www.apollotherapeutics.com Semrush global rank: 5.75 M Semrush visits lastest month: 1.45 K
- Host name: ec2-18-171-93-28.eu-west-2.compute.amazonaws.com
- IP address: 18.171.93.28
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago